Study to Determine Potential for Drug-drug Interactions When Co-administering Deupirfenidone (LYT-100) and Nintedanib

Clinical trial NCT06717100 · COMPLETED

Trial details

NCT number: NCT06717100
Sponsor: PureTech
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Drug Interactions

Start date: 2024-12-17
Primary completion: 2025-02-17
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.